½ÃÀ庸°í¼­
»óǰÄÚµå
1593990

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : Á¦Ç° À¯Çü, ÇüÅ À¯Çüº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Medical 3D Printing Plastics Market by Product Type (ABS, PEEK, PETG), Form Type (Filament, Ink, Powder) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀº 2023³â¿¡ 5¾ï 4,617¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 6¾ï 9,504¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 27.35%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 29¾ï 6,723¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¹üÀ§´Â ÀÇ·á±â±â, ÀÓÇöõÆ®, º¸Ã¶¹°, ÇØºÎÇÐ ¸ðµ¨À» °³¹ßÇϱâ À§ÇÑ 3D ÇÁ¸°ÆÃ¿¡¼­ ÇÃ¶ó½ºÆ½ Àç·áÀÇ »ý»ê ¹× Ȱ¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡¼­ Áß¿äÇÑ °ÍÀº ¸ÂÃãÇü ÀÇ·áÀÇ Çʿ伺°ú 3D ÇÁ¸°ÆÃÀ» ÅëÇÑ È¯ÀÚº° ¸ðµ¨ ¹× Àåºñ Á¦ÀÛ ´É·ÂÀ¸·Î ÀÎÇØ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¿ëµµ¿¡´Â Á¤Çü¿Ü°ú, Ä¡°ú, ¼ö¼ú ±â±¸, ¹ÙÀÌ¿À ÇÁ¸°ÆÃ µîÀÌ Æ÷ÇԵǸç, ÃÖÁ¾ »ç¿ëó´Â º´¿ø°ú ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)ºÎÅÍ ¿¬±¸ ±â°ü°ú Áø´Ü ½ÇÇè½Ç±îÁö ´Ù¾çÇÕ´Ï´Ù. ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â 3D ÇÁ¸°ÆÃ ±â¼úÀÇ ¹ßÀü, R&D ÅõÀÚ Áõ°¡, »ýü ÀûÇÕ¼º Àç·áÀÇ Ã¤Åà µîÀÌ ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ȯ°æ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¹ÙÀÌ¿ÀÆú¸®¸Ó ¹× »ýºÐÇØ¼º ¼ÒÀçÀÇ Ãß°¡ °³¹ß, ¼ö¼ú¿ë ºñ°è Àç·á ¹× ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡µµ Àû¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ °úÁ¦·Î´Â ³ôÀº Ãʱ⠼³Á¤ ºñ¿ë°ú Á¦Ç° Ãâ½Ã ¹× Çõ½Å Áֱ⸦ Áö¿¬½ÃŰ´Â ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö¿¡ ´ëÇÑ ¿ä±¸°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ °øÁ¤°ú Àç·á°¡ Ç¥ÁØÈ­µÇ¾î ÀÖÁö ¾Ê´Ù´Â Á¡µµ ½ÃÀå È®»ê¿¡ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å ºÎ¹®¿¡´Â ´ÙÁß Àç·á ÇÁ¸°ÆÃ ±â´É °³¹ß, º¹ÀâÇÑ Á¶Á÷°øÇÐÀ» À§ÇÑ Ã·´Ü ¹ÙÀÌ¿À À×Å©, Á¤¹Ð ¸ðµ¨¸µ ¹× ½Ã¹Ä·¹À̼ÇÀ» À§ÇÑ Çâ»óµÈ ¼ÒÇÁÆ®¿þ¾î µîÀÌ Æ÷ÇԵ˴ϴÙ. ±â¾÷Àº ¹ÙÀÌ¿ÀÅ×Å© ±â¾÷ ¹× ¿¬±¸±â°ü°úÀÇ ÇÕº´ ¹× Á¦ÈÞ¿¡ Àü·«ÀûÀ¸·Î ÁýÁßÇÏ¿© R&D ³ë·ÂÀ» °­È­ÇÏ´Â ÇÑÆí, ºñ¿ë È¿À²¼ºÀ» ³ôÀÌ°í ¼Ò±Ô¸ð ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÁøÀÔÀ庮À» ³·Ãß´Â µ¥ ÁÖ·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, ±â¼ú ¹ßÀü°ú ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ Ư¡ÀÔ´Ï´Ù. ±â¾÷Àº »õ·Î¿î µ¿ÇâÀ» Ȱ¿ëÇϱâ À§ÇØ À¯¿¬Çϰí Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ» À¯ÁöÇϰí Áö¼Ó°¡´É¼º°ú ȯÀÚ Áß½ÉÀÇ ¿ëµµ¿¡ ÁßÁ¡À» µÎ¾î ÀÌ º¯È­ÀÇ ½Ã±â¿¡ °æÀï ¿ìÀ§¸¦ À¯ÁöÇÏ°í ºñÁî´Ï½º ¼ºÀåÀ» °¡¼ÓÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 5¾ï 4,617¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 6¾ï 9,504¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 29¾ï 6,723¸¸ ´Þ·¯
CAGR(%) 27.35%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÇ·á Àü¹®°¡µéÀÌ °³ÀÎÈ­µÈ ÀÇ·á±â±â ¹× ȯÀÚº° ÀÓÇöõÆ® »ç¿ëÀ» À§ÇØ 3D ÇÁ¸°ÆÃ ±â¼úÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
    • Ä¡°ú ¹× »À ÀÓÇöõÆ®, Ä«Å×ÅÍ, º¸Ã¶¹° ¹× ±âŸ ÀÇ·á±â±â µî ÀÇ·á Á¦Ç° »ý»ê Áõ°¡
    • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ÀÇ ³ôÀº Á¦Á¶ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½¿¡ ´ëÇÑ R&D ÅõÀÚ È®´ë
  • ½ÃÀå °úÁ¦
    • 3D ÇÁ¸°ÆÃµÈ ¹°Ã¼ÀÇ Ç°ÁúÀÌ ÀÏÁ¤ÇÏÁö ¾Ê½À´Ï´Ù.
    • 3D ÇÁ¸°ÆÃµÈ ÇÃ¶ó½ºÆ½ ¹°Ã¼¿Í °ü·ÃµÈ ȯ°æ ºñ¿ë

Porter's Five Forces: ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼­·Ð
  • ABS
  • PEEK
  • PETG
  • Æ÷ÅäÆú¸®¸Ó
  • Æú¸®¾Æ¹Ìµå
  • Æú¸®À¯»ê

Á¦7Àå ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå : ÇüÅ À¯Çüº°

  • ¼­·Ð
  • Çʶó¸àÆ®
  • À×Å©
  • ºÐ¸»

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • 3D HUBS B.V.
  • 3D Systems, Inc.
  • Apium Additive Technologies GmbH
  • Arkema SA
  • BASF SE
  • Clariant AG
  • CRP Group
  • Dowdupont de Numourous Inc.
  • EnvisionTEC, Inc.
  • EOS GmbH
  • Evonik Industries AG
  • Henkel AG & Co. KGaA
  • Javelin Technologies Inc.
  • Koninklijke DSM N.V.
  • RapidMade Inc.
  • Renishaw PLC
  • Saudi Basic Industries Corporation
  • Solvay SA
  • Stratasys, Ltd.
  • Victrex Plc
KSA 24.11.28

The Medical 3D Printing Plastics Market was valued at USD 546.17 million in 2023, expected to reach USD 695.04 million in 2024, and is projected to grow at a CAGR of 27.35%, to USD 2,967.23 million by 2030.

The scope of the Medical 3D Printing Plastics market encompasses the production and utilization of plastic materials in 3D printing to develop medical devices, implants, prosthetics, and anatomical models. Critical to this market is the rising demand for customized medical solutions, driven by the necessity for personalized medicine and the capability of 3D printing to produce patient-specific models and devices. Applications include orthopedics, dental, surgical instruments, and bioprinting, with end-use segments ranging from hospitals and ambulatory surgery centers to research institutions and diagnostic labs. Key growth factors influencing the market include advancements in 3D printing technology, increasing R&D investments, and the adoption of biocompatible materials. Emerging opportunities lie in further developing biopolymers and biodegradable materials to address environmental concerns, which also hold potential in surgical scaffoldings and drug delivery systems. However, market growth is challenged by high initial setup costs and a need for stringent regulatory compliance which can delay product launches and innovation cycles. Moreover, a lack of standardized processes and materials across the industry could hamper broader adoption. Areas of innovation include the development of multi-material printing capabilities, advanced bioinks for complex tissue engineering, and enhanced software for precision modeling and simulations. Businesses could strategically focus on mergers or partnerships with biotech firms and research institutions to bolster their R&D efforts, while also addressing cost efficiencies to lower barriers to entry for smaller healthcare providers. The nature of the market is dynamic and rapidly evolving, characterized by technological advancements and increased investment in healthcare solutions. Companies should remain flexible and proactive in their approach to leverage emerging trends, focusing on sustainability and patient-specific applications to maintain competitive advantage and drive business growth in this transformational industry.

KEY MARKET STATISTICS
Base Year [2023] USD 546.17 million
Estimated Year [2024] USD 695.04 million
Forecast Year [2030] USD 2,967.23 million
CAGR (%) 27.35%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical 3D Printing Plastics Market

The Medical 3D Printing Plastics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of 3D printing technology by medical professionals to use personalized medical devices and patient-specific implants
    • Rising manufacturing of medical products, such as dental and bone implants, catheters, prosthetics, and other medical devices
    • Government support for 3D printing plastics in medical
  • Market Restraints
    • High production cost of 3D printed plastic
  • Market Opportunities
    • Rising R&D investments in the medical 3D printing plastics
  • Market Challenges
    • Inconsistent quality of 3D-printed objects
    • Environmental cost associated with the 3D printed plastic objects

Porter's Five Forces: A Strategic Tool for Navigating the Medical 3D Printing Plastics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical 3D Printing Plastics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical 3D Printing Plastics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical 3D Printing Plastics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical 3D Printing Plastics Market

A detailed market share analysis in the Medical 3D Printing Plastics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical 3D Printing Plastics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical 3D Printing Plastics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical 3D Printing Plastics Market

A strategic analysis of the Medical 3D Printing Plastics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical 3D Printing Plastics Market, highlighting leading vendors and their innovative profiles. These include 3D HUBS B.V., 3D Systems, Inc., Apium Additive Technologies GmbH, Arkema SA, BASF SE, Clariant AG, CRP Group, Dowdupont de Numourous Inc., EnvisionTEC, Inc., EOS GmbH, Evonik Industries AG, Henkel AG & Co. KGaA, Javelin Technologies Inc., Koninklijke DSM N.V., RapidMade Inc., Renishaw PLC, Saudi Basic Industries Corporation, Solvay SA, Stratasys, Ltd., and Victrex Plc.

Market Segmentation & Coverage

This research report categorizes the Medical 3D Printing Plastics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across ABS, PEEK, PETG, Photopolymer, Polyamide, and Polylactic Acid.
  • Based on Form Type, market is studied across Filament, Ink, and Powder.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of 3D printing technology by medical professionals to use personalized medical devices and patient-specific implants
      • 5.1.1.2. Rising manufacturing of medical products, such as dental and bone implants, catheters, prosthetics, and other medical devices
      • 5.1.1.3. Government support for 3D printing plastics in medical
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost of 3D printed plastic
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D investments in the medical 3D printing plastics
    • 5.1.4. Challenges
      • 5.1.4.1. Inconsistent quality of 3D-printed objects
      • 5.1.4.2. Environmental cost associated with the 3D printed plastic objects
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical 3D Printing Plastics Market, by Product Type

  • 6.1. Introduction
  • 6.2. ABS
  • 6.3. PEEK
  • 6.4. PETG
  • 6.5. Photopolymer
  • 6.6. Polyamide
  • 6.7. Polylactic Acid

7. Medical 3D Printing Plastics Market, by Form Type

  • 7.1. Introduction
  • 7.2. Filament
  • 7.3. Ink
  • 7.4. Powder

8. Americas Medical 3D Printing Plastics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical 3D Printing Plastics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical 3D Printing Plastics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D HUBS B.V.
  • 2. 3D Systems, Inc.
  • 3. Apium Additive Technologies GmbH
  • 4. Arkema SA
  • 5. BASF SE
  • 6. Clariant AG
  • 7. CRP Group
  • 8. Dowdupont de Numourous Inc.
  • 9. EnvisionTEC, Inc.
  • 10. EOS GmbH
  • 11. Evonik Industries AG
  • 12. Henkel AG & Co. KGaA
  • 13. Javelin Technologies Inc.
  • 14. Koninklijke DSM N.V.
  • 15. RapidMade Inc.
  • 16. Renishaw PLC
  • 17. Saudi Basic Industries Corporation
  • 18. Solvay SA
  • 19. Stratasys, Ltd.
  • 20. Victrex Plc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦